title: Single-dose pharmacokinetics, safety, and tolerability of modified-release formulations of lersivirine in healthy subjects.
authors.affiliation: Pfizer Global Research and Development, New York, NY, USA.
authors.forename: Manoli
authors.initials: M
authors.lastname: Vourvahis
authors.affiliation: Pfizer Global Research and Development, Groton, CT, USA.
authors.forename: Ronnie
authors.initials: R
authors.lastname: Wang
authors.affiliation: Pfizer Clinical Research Unit, Brussels, Belgium.
authors.forename: Laure
authors.initials: L
authors.lastname: Mendes da Costa
authors.affiliation: Pfizer Global Research and Development, Groton, CT, USA.
authors.forename: Cunshan
authors.initials: C
authors.lastname: Wang
authors.affiliation: Pfizer Global Research and Development, Sandwich, Kent, UK.
authors.forename: Barry
authors.initials: B
authors.lastname: Weatherley
authors.affiliation: Pfizer Global Research and Development, New York, NY, USA.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Mukwaya
authors.affiliation: Pfizer Global Research and Development, Groton, CT, USA.
authors.forename: Margaret
authors.initials: M
authors.lastname: Tawadrous
authors.affiliation: Pfizer Global Research and Development, Groton, CT, USA.
authors.forename: Jayvant
authors.initials: J
authors.lastname: Heera
keywords: bioavailability; food; lersivirine; modified-release; pharmacokinetics